The global Interventional Pulmonology market gathered revenue around USD 3.2 Billion in 2020 and market is set to grow USD 7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.4% during the prediction period 2021 to 2027. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest by using minimally invasive techniques. Rise in prevalence of respiratory disorders, increase in geriatric population, and surge in incidence of diseases that require endoscopic ultrasound procedures are the major factors anticipated to drive the global interventional pulmonology market during the forecast period.
North America held a major share of the global interventional pulmonology market in 2020 due to the high demand for interventional pulmonology devices. Additionally, technological advancements drive demand for interventional pulmonology devices, which is expected to augment the market in the region. The interventional pulmonology market in Asia Pacific is likely to expand at a high CAGR of 9.20% from 2021 to 2027 due to increase in acceptance of technological platforms across various fields.
The report includes an elaborate executive summary, which provides a snapshot of various segments of the global interventional pulmonology market. It also provides information and data analysis of the global interventional pulmonology market with regards to segments based on product type, indication, end user, and region.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Interventional Pulmonology market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Interventional Pulmonology market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Interventional Pulmonology market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America to Dominate Global Market; Asia Pacific to Offer Significant Opportunities
In terms of region, the global interventional pulmonology market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for a leading share of the global interventional pulmonology market during the forecast period. The interventional pulmonology market in Asia Pacific is expected to grow at a rapid pace in the near future. India and China are likely to be lucrative markets for interventional pulmonology during the forecast period.
Interventional Pulmonology Market: Regional Outlook
In terms of region, the global interventional pulmonology market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
The global interventional pulmonology market report provides size and forecast for each region and country/sub-region from 2017 to 2027. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The interventional pulmonology market study also covers the competitive scenario in these regions.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Interventional Pulmonology Market are:
the global interventional pulmonology market are Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG, Medtronic, Olympus Corporation, Pennine Healthcare, PENTAX Medical, Pulmonx Corporation, Richard Wolf GmbH, Rocket Medical plc., TAEWOONG, and Vygon, among others.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Interventional Pulmonology Market: Segmentation
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
The study objectives of this report are: